These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23547634)

  • 1. Differences in adjustment between individuals with alpha-1 antitrypsin deficiency (AATD)-associated COPD and non-AATD COPD.
    Holm KE; Borson S; Sandhaus RA; Ford DW; Strange C; Bowler RP; Make BJ; Wamboldt FS
    COPD; 2013 Apr; 10(2):226-34. PubMed ID: 23547634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients.
    Karl FM; Holle R; Bals R; Greulich T; Jörres RA; Karch A; Koch A; Karrasch S; Leidl R; Schulz H; Vogelmeier C; Wacker ME;
    Respir Res; 2017 Apr; 18(1):60. PubMed ID: 28416015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of age on outcomes in chronic obstructive pulmonary disease differs by relationship status.
    Holm KE; Plaufcan MR; Ford DW; Sandhaus RA; Strand M; Strange C; Wamboldt FS
    J Behav Med; 2014 Aug; 37(4):654-63. PubMed ID: 23645147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency - analysis from the German Registry.
    Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R; Fähndrich S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1427-1437. PubMed ID: 28553095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of the CAT, LCOPD, EQ-5D and COPDSS scales in understanding the impact of lung disease in patients with alpha-1 antitrypsin deficiency.
    Manca S; Rodriguez E; Huerta A; Torres M; Lazaro L; Curi S; Pirina P; Miravitlles M
    COPD; 2014 Sep; 11(5):480-8. PubMed ID: 24832005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung transplantation and survival outcomes in patients with oxygen-dependent COPD with regard to their alpha-1 antitrypsin deficiency status.
    Ekström M; Tanash H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3281-3287. PubMed ID: 29158672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of smoke exposure on the clinical phenotype of alpha-1 antitrypsin deficiency in Ireland: exploiting a national registry to understand a rare disease.
    O'Brien ME; Pennycooke K; Carroll TP; Shum J; Fee LT; O'Connor C; Logan PM; Reeves EP; McElvaney NG
    COPD; 2015 May; 12 Suppl 1():2-9. PubMed ID: 25938284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decline in FEV
    Hiller AM; Piitulainen E; Jehpsson L; Tanash H
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1075-1083. PubMed ID: 31213789
    [No Abstract]   [Full Text] [Related]  

  • 9. Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD.
    Balbi B; Sangiorgi C; Gnemmi I; Ferrarotti I; Vallese D; Paracchini E; Delle Donne L; Corda L; Baderna P; Corsico A; Carone M; Brun P; Cappello F; Ricciardolo FL; Ruggeri P; Mumby S; Adcock IM; Caramori G; Di Stefano A
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1879-1893. PubMed ID: 31686800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review.
    Edgar RG; Patel M; Bayliss S; Crossley D; Sapey E; Turner AM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1295-1308. PubMed ID: 28496314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical costs of Alpha-1 antitrypsin deficiency-associated COPD in the United States.
    Sieluk J; Slejko JF; Silverman H; Perfetto E; Mullins CD
    Orphanet J Rare Dis; 2020 Sep; 15(1):260. PubMed ID: 32967697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease.
    Stoller JK; Aboussouan LS; Kanner RE; Wilson LA; Diaz P; Wise R;
    Ann Am Thorac Soc; 2015 Dec; 12(12):1796-804. PubMed ID: 26653189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exacerbations and duration of smoking abstinence are associated with the annual loss of FEV
    Fähndrich S; Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R
    Respir Med; 2017 Aug; 129():8-15. PubMed ID: 28732839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled corticosteroids as additional treatment in alpha-1-antitrypsin-deficiency-related COPD.
    Corda L; Bertella E; La Piana GE; Boni E; Redolfi S; Tantucci C
    Respiration; 2008; 76(1):61-8. PubMed ID: 18319586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of exercise training responses in COPD patients with and without Alpha-1 antitrypsin deficiency.
    Jarosch I; Hitzl W; Koczulla AR; Wencker M; Welte T; Gloeckl R; Janciauskiene S; Kenn K
    Respir Med; 2017 Sep; 130():98-101. PubMed ID: 29206641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe alpha-1-antitrypsin deficiency increases the risk of venous thromboembolism.
    Basil N; Ekström M; Piitulainen E; Lindberg A; Rönmark E; Jehpsson L; Tanash H
    J Thromb Haemost; 2021 Jun; 19(6):1519-1525. PubMed ID: 33763945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics associated with SF-36 in alpha-1 antitrypsin deficiency-associated COPD: a cross-sectional analysis.
    Choate R; Holm KE; Sandhaus RA; Mannino DM; Strange C
    BMC Pulm Med; 2024 Mar; 24(1):138. PubMed ID: 38500152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.
    Lascano JE; Campos MA
    Postgrad Med; 2017 Nov; 129(8):889-895. PubMed ID: 28929906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-1 Antitrypsin Deficiency-Associated Chronic Obstructive Pulmonary Disease: A Family Perspective.
    Anzueto A
    COPD; 2015 Aug; 12(4):462-7. PubMed ID: 25474273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients 'on' or 'off' augmentation therapy.
    Olfert IM; Malek MH; Eagan TM; Wagner H; Wagner PD
    BMC Pulm Med; 2014 Jun; 14():106. PubMed ID: 24975928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.